Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-36011835

RESUMO

BACKGROUND: Metabolic syndrome (MS) is associated with greater risk of morbimortality and it has high prevalence in people with mental illness. OBJECTIVE: Estimate the prevalence of Metabolic Syndrome (MS) and its associated factors in the patients of a Psychosocial Care Center (CAPS in Brazilian Portuguese) in the city of Salvador, state of Bahia, Brazil. METHOD: Cross-sectional study set at CAPS in the city of Salvador-Bahia between August 2019 and February 2020. MS was evaluated according to the National Cholesterol Education Program's Adult Treatment Panel III. In addition to descriptive statistics, gross and adjusted prevalence ratios were described. RESULTS: MS was found in 100 (35.2%) individuals, 116 (40.9%) were obese and 165 (58.1%) had increased waist circumference. Polypharmacy was identified in 63 (22.3%) patients and 243 (85.9%) used antipsychotics. Under gross evaluation, women (PR = 1.88; 95%CI: 1.35-2.63) and those who used antidepressants (PR = 1.41; 95%CI: 1.05-1.88) showed an association with MS. After logistic regression, depression (PR = 1.86; 95%CI: 1.38-2.51), acanthosis (PR = 1.50; 95%CI: 1.18-1.90), use of antipsychotics (PR = 1.88; 95%CI: 1.13-2.75), and hypertriglyceridemic waist (PR = 3.33; 95%CI: 2.48-4.46) were associated with MS. CONCLUSION: The prevalence of MS signals multimorbidity among individuals with mental disorders and suggests a need for clinical screening.


Assuntos
Antipsicóticos , Síndrome Metabólica , Reabilitação Psiquiátrica , Adulto , Antipsicóticos/uso terapêutico , Brasil/epidemiologia , Estudos Transversais , Feminino , Humanos , Síndrome Metabólica/diagnóstico , Síndrome Metabólica/epidemiologia , Prevalência , Fatores de Risco
2.
Work ; 71(3): 739-748, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35253673

RESUMO

BACKGROUND: Cross-sectional studies point out important evidence between anxiety and dyslipdemic disorders in health workers. OBJECTIVE: Our main objective was to estimate the association between anxiety and dyslipidemia in Primary Health Care (PHC) nursing professionals in Feira de Santana, Bahia, Brazil. METHODS: A confirmatory cross-sectional study involving 376 PHC nursing professionals. Data collection occurred through the application of a questionnaire containing sociodemographic, labor and lifestyle issues, and the Beck Inventory for anxiety; to evaluate the lipid profile, the HDL-c, LDL-c, and triglycerides markers were evaluated. Descriptive, bivariate analysis and Logistic Regression were performed. RESULTS: The estimated prevalence of moderate/severe anxiety corresponded to 26.1% and dyslipidemia was 54.8%, with a statistically significant association between both of variables stratified by physical activity (PR = 2.69; 95% CI = 1.87-3.85) and (PR = 1.87; 95% CI = 1.53-2.28). CONCLUSIONS: There is a positive association between anxiety and dyslipidemia in Primary Health Care nursing professionals.


Assuntos
Transtornos de Ansiedade , Dislipidemias , Ansiedade/epidemiologia , Brasil/epidemiologia , Estudos Transversais , Dislipidemias/complicações , Dislipidemias/epidemiologia , Pessoal de Saúde , Humanos , Prevalência
3.
Healthcare (Basel) ; 10(3)2022 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-35327022

RESUMO

Metabolic syndrome (MS) is a clinical condition and a relevant risk factor in the development of cardiovascular diseases; it occurs as a result of lifestyle factors, e.g., work. The aim of this research was to estimate the interaction between work and MS among primary health care (PHC) nursing professionals in the state of Bahia, Brazil. A sectional multicentered study carried out in 43 municipalities in Bahia, whose study population consisted of nursing professionals. The exposure variables were occupation, professional exhaustion, and working time, and the outcome variable was MS. Interaction measures based on the additivity criteria were verified by calculating the excess risks due to the interactions and according to the proportion of cases attributed to the interactions and the synergy index. The global MS prevalence is 24.4%. There was a greater magnitude in the exposure group regarding the three investigated factors (average level occupation, professional exhaustion, and working time in PHC for more than 5 years), reaching an occurrence of 44.9% when compared to the prevalence of 13.1% in the non-exposure group (academic education, without professional burnout, and working time in PHC for up to 5 years). The study's findings showed a synergistic interaction of work aspects for MS occurrence among PHC nursing professionals.

4.
Nutr Hosp ; 39(1): 20-26, 2022 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-34839672

RESUMO

INTRODUCTION: Introduction: patients with COVID-19 undergo changes in leukocyte count, respiratory disorders, and an increase in inflammatory substances. To improve the inflammatory condition, some nutrients can be used, including arginine, omega-3 fatty acids and nucleotides. This study aims to evaluate how oral immunonutrient supplements affects serum C-reactive protein (CRP) levels and lymphocyte count in patients with COVID-19. Methods: in this double-blind clinical trial, we randomized 43 adult patients with COVID-19 to receive a standard high-protein normocaloric supplement (control) or an immunonutrient-enriched supplement (experiment) for 7 days. The primary outcome was to evaluate changes in total lymphocyte count and serum level of CRP. The assessment of risk and nutritional status of these patients was also performed. Results: forty-three patients with mean age of 41.5 (± 1.8) years were followed up, 39.5 % of them women. The mean body mass index was 27.6 (± 0.8) kg/m² and 58.1 % had low nutritional risk. In the experiment group, there was a CRP reduction of 23.6 (± 7.5) mg/L, while in the control branch the decrease was 14.8 (± 12.1) mg/L (p = 0.002). There was an increase in lymphocytes in the experiment group (+367.5 ± 401.8 cells/mm³) and a reduction in the control group (-282.8 ± 327.8 cells/mm³), although there was no statistical significance (p = 0.369). Relative risk (RR) of treatment in reducing CRP by 30 % or more was 4.45 (p < 0.001; 95 % CI, 1.79-11.07). RR in increasing lymphocyte count by 30 % or more was 1.28 (p = 0.327; 95 % CI, 0.67-2.45). Conclusion: we conclude that immunonutrient supplements seem to reduce CRP levels more than standard high-protein normocaloric supplements.


INTRODUCCIÓN: Introducción: los pacientes con COVID-19 sufren cambios en el recuento de leucocitos, trastornos respiratorios y aumento de sustancias inflamatorias. Para mejorar la condición inflamatoria se pueden usar algunos nutrientes, como la arginina, los ácidos grasos omega-3 y los nucleótidos. Este estudio tiene como objetivo evaluar cómo los suplementos de inmunonutrientes orales afectan a los niveles séricos de proteína C-reactiva (PCR) y al recuento de linfocitos en pacientes con COVID-19. Métodos: en este ensayo clínico doble ciego, aleatorizamos a 43 pacientes adultos con COVID-19 para recibir un suplemento normocalórico estándar alto en proteínas (control) o un suplemento enriquecido con inmunonutrientes (experimento) durante 7 días. El resultado primario fue evaluar los cambios en el recuento total de linfocitos y el nivel sérico de PCR. También se realizó la evaluación del riesgo y el estado nutricional de estos pacientes. Resultados: cuarenta y tres pacientes con edad media de 41,5 (± 1,8) años fueron seguidos, el 39,5 % de ellos mujeres. El índice de masa corporal medio fue de 27,6 (± 0,8) kg/m² y el 58,1 % tenían bajo riesgo nutricional. En el grupo experimental hubo una reducción de la PCR de 23,6 (± 7,5) mg/L, mientras que en la rama de control la disminución fue de 14,8 (± 12,1) mg/L (p = 0,002). Hubo un aumento de linfocitos en el grupo experimental (+367,5 ± 401,8 células/mm³) y una reducción en el grupo de control (-282,8 ± 327,8 células/mm³), aunque no hubo significación estadística (p = 0,369). El riesgo relativo (RR) del tratamiento para reducir la PCR en un 30 % o más fue de 4,45 (p < 0,001; IC 95 %: 1,79-11,07). El RR en el aumento del recuento de linfocitos en un 30 % o más fue de 1,28 (p = 0,327; IC 95 %: 0,67-2,45). Conclusión: se concluye que los suplementos de inmunonutrientes parecen reducir los niveles de PCR más que los suplementos normocalóricos estándar altos en proteína.


Assuntos
Proteína C-Reativa , COVID-19 , Adulto , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Humanos , Linfócitos , SARS-CoV-2
5.
Rev Lat Am Enfermagem ; 30: e3771, 2022.
Artigo em Inglês, Português, Espanhol | MEDLINE | ID: mdl-36629728

RESUMO

OBJECTIVE: to assess the effectiveness of auriculotherapy in reducing occupational stress among Family Health Strategy workers during the COVID-19 pandemic. METHOD: a controlled randomized clinical trial divided into two groups, namely: auriculotherapy for stress group and placebo group. The Shapiro-Wilk test was used to assess data normality. The ANOVA test for repeated measures and the Tukey post-hoc test were applied to the group with normal samples. In turn, the Friedman and Durbin-Conover tests were employed in the group with non-normal distribution. Cohen's d index was calculated for the therapy effect size. A 95% significance level and p<0.05 were considered. RESULTS: the auriculotherapy group presented 16.3% and 23.7% reductions in occupational stress after the third and sixth auriculotherapy sessions, with Cohen's d indices of 1.12 (large effect) and 1.82 (very large effect), respectively. CONCLUSION: auriculotherapy proved to be effective in reducing occupational stress among Family Health Strategy workers during the COVID-19 pandemic. It is suggested that new studies are developed both during and after the pandemic in order to improve health workers' Quality of Life. ReBEC registration: RBR - 38hjyt3.


Assuntos
Auriculoterapia , COVID-19 , Estresse Ocupacional , Humanos , Qualidade de Vida , Pandemias , Estresse Ocupacional/prevenção & controle
6.
Rev. latinoam. enferm. (Online) ; 30: e3771, 2022. tab, graf
Artigo em Inglês | LILACS, BDENF - Enfermagem | ID: biblio-1424030

RESUMO

Abstract Objective: to assess the effectiveness of auriculotherapy in reducing occupational stress among Family Health Strategy workers during the COVID-19 pandemic. Method: a controlled randomized clinical trial divided into two groups, namely: auriculotherapy for stress group and placebo group. The Shapiro-Wilk test was used to assess data normality. The ANOVA test for repeated measures and the Tukey post-hoc test were applied to the group with normal samples. In turn, the Friedman and Durbin-Conover tests were employed in the group with non-normal distribution. Cohen's d index was calculated for the therapy effect size. A 95% significance level and p<0.05 were considered. Results: the auriculotherapy group presented 16.3% and 23.7% reductions in occupational stress after the third and sixth auriculotherapy sessions, with Cohen's d indices of 1.12 (large effect) and 1.82 (very large effect), respectively. Conclusion: auriculotherapy proved to be effective in reducing occupational stress among Family Health Strategy workers during the COVID-19 pandemic. It is suggested that new studies are developed both during and after the pandemic in order to improve health workers' Quality of Life. ReBEC registration: RBR - 38hjyt3.


Resumo Objetivo: avaliar a efetividade da auriculoterapia na redução do estresse ocupacional em trabalhadores de saúde da Estratégia de Saúde da Família durante a pandemia da COVID-19. Método: ensaio clínico controlado randomizado em dois grupos: grupo auriculoterapia para o estresse e grupo placebo. Foi utilizado o teste de Shapiro-Wilk para avaliar a normalidade dos dados. O teste ANOVA de medidas repetidas e o teste post-hoc Tukey foram aplicados para o grupo com amostras normais. Já o teste de Friedman e de Durbin-Conover foram utilizados no grupo com distribuição não normal. Para o tamanho do efeito da terapia, foi calculado o índice d de Cohen. Considerou-se o nível de significância de 95% e valor p<0,05. Resultados: o grupo auriculoterapia apresentou redução do estresse ocupacional de 16,3 e 23,7% após a terceira e sexta sessões de auriculoterapia, com índices d de Cohen de 1,12 (grande efeito) e 1,82 (efeito muito grande), respectivamente. Conclusão: a auriculoterapia mostrou-se efetiva na redução do estresse ocupacional em trabalhadores de saúde da Estratégia Saúde da Família durante a pandemia da COVID-19. Sugere-se que novos estudos sejam desenvolvidos durante e após a pandemia de maneira a melhorar a qualidade de vida dos trabalhadores de saúde. Registro ReBEC: RBR - 38hjyt3.


Resumen Objetivo: evaluar la efectividad de la auriculoterapia para la reducción del estrés laboral en trabajadores de salud de la Estrategia Salud de la Familia durante la pandemia de COVID-19. Método: ensayo clínico controlado aleatorizado en dos grupos: grupo auriculoterapia para el estrés y grupo placebo. Se utilizó la prueba de Shapiro-Wilk para evaluar la normalidad de los datos. Al grupo con muestras normales se les aplicó la prueba ANOVA de medidas repetidas y la prueba post-hoc de Tukey. Se utilizaron las pruebas de Friedman y Durbin-Conover en el grupo con distribución no normal. Para el tamaño del efecto de la terapia se calculó el índice d de Cohen. Se consideró un nivel de significación del 95% y un valor de p <0,05. Resultados: el grupo auriculoterapia mostró una reducción del estrés laboral de 16,3 y 23,7% después de la tercera y sexta sesión de auriculoterapia, con índices d de Cohen de 1,12 (efecto grande) y 1,82 (efecto muy grande), respectivamente. Conclusión: la auriculoterapia demostró ser eficaz para la reducción del estrés laboral en trabajadores de la salud de la Estrategia Salud de la Familia durante la pandemia de COVID-19. Se sugiere desarrollar nuevos estudios durante y después de la pandemia con el fin de mejorar la calidad de vida de los trabajadores de la salud. Registro ReBEC: RBR - 38hjyt3.


Assuntos
Humanos , Saúde Ocupacional , Auriculoterapia , Estresse Ocupacional/terapia , Estresse Ocupacional/epidemiologia , COVID-19 , Métodos Terapêuticos Complementares
7.
Rev. bras. hipertens ; 28(1): 35-38, 10 març. 2021.
Artigo em Português | LILACS | ID: biblio-1367868

RESUMO

Pressão Central, como o nome indica, é uma medida hemodinâmica semelhante a pressão arterial convencional porém avaliada de forma indireta por equipamento especifico, que avalia estes parâmetros na saída do sangue na raiz da aorta. Esta medida tem uma maior confiabilidade pois prediz de forma mais acurada os riscos de adoecimento e morte cardiovascular. Isto ocorre, pois a a onda de pulso (OP) ao percorrer os trajetos arteriais sofrem ampliações e importantes modificações no seu contorno deformando o valor original. Embora seja mais precisa em valores, ainda não é usado de rotina na pratica clinica por razoes de custos dos seus equipamentos e provavelmente por exigir habilidades maiores que as medidas captadas pelo equipamentos de mensuração periférica


Central pressure, as the name implies, is a hemodynamic measure similar to conventional blood pressure, but indirectly assessed by specific equipment, which evaluates these parameters at the blood outlet at the root of the aorta. This measure has greater confidence because it more accurately predicts the risks of cardiovascular disease and death. This occurs because the pulse wave (OP) when traversing the arterial paths provides enlargements and modifications in its contour, deforming the original value. Although it is more precise in terms of values, it is not yet routinely used in clinical practice for reasons of the cost of its equipment and probably because it requires greater needs than measures captured by peripheral measurement equipment


Assuntos
Pressão Venosa Central/fisiologia , Análise de Onda de Pulso , Fatores de Risco de Doenças Cardíacas
8.
Artigo em Inglês | MEDLINE | ID: mdl-33499303

RESUMO

BACKGROUND: Labor activities are demanding for workers and can induce occupational stress. Primary health care (PHC) workers have faced problems that can lead to the development of stress and abdominal obesity. The aim of this study was to estimate the prevalence of abdominal adiposity among primary health care physicians in the metropolitan mesoregion of Salvador, Bahia. METHODS: This is a cross-sectional study conducted with physicians from the family health units (FHUs) of the metropolitan mesoregion of Salvador, Bahia, Brazil. The number of FHUs corresponded to 41 teams (52 physicians). Anamnesis was performed and a questionnaire was applied. The clinical examination consisted of measuring waist circumference (WC), blood pressure levels (BP), and body mass index (BMI), as well as examining for acanthosis nigricans. Blood samples were collected for biochemical dosages. The data obtained were analyzed by SPSS version 22.0. RESULTS: The sample included 41 physicians (response rate: 78.8%), of which 18 were women (44.0%). The percentage of overweight participants represented by BMI was 31.7%. The hypertriglyceridemia prevalence was 29.2%. HDL-c was low in 48.7% of the participants. The waist circumference measurement revealed a prevalence of abdominal adiposity of 38.8% (women) and 34.8% (men). CONCLUSIONS: Medical professionals in PHC are more susceptible to having higher abdominal adiposity, especially female physicians.


Assuntos
Obesidade Abdominal , Adiposidade , Índice de Massa Corporal , Brasil/epidemiologia , Estudos Transversais , Estudos Epidemiológicos , Feminino , Humanos , Masculino , Obesidade Abdominal/epidemiologia , Prevalência , Atenção Primária à Saúde , Circunferência da Cintura
9.
Rev Bras Med Trab ; 19(3): 283-289, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-35774764

RESUMO

Introduction: The high levels of anxiety, stress, and depression produced by the global Coronavirus disease 2019 pandemic could trigger eating disorders. Health professionals are more exposed to these changes due to their work environment. Objectives: To evaluate the relationship between the COVID-19 pandemic and the onset of binge eating disorder and psychiatric disorders in Brazilian health professionals. Methods: This descriptive, prospective, cross-sectional study interviewed 219 Brazilian health professionals between June and October 2020 using an online questionnaire. The 7-Item Binge Eating Disorder Screener was used to diagnose binge eating disorder. The Self-Reporting Questionnaire was used to assess psychiatric disorders. The statistical analysis included calculation of absolute frequency, relative frequency, mean and standard deviation. Contingency coefficient C was used to determine the association between the variables. Results: A total of 35 (16%) participants reported symptoms related to binge eating disorder, while 131 (59.8%) reported psychiatric symptoms. There was an association between binge eating disorder, psychiatric disorders, and body mass index. Conclusions: Our findings suggest the onset of psychiatric disorders and binge eating disorders in these professionals and that elevated body mass index is directly associated with these disorders.

11.
Nutr Hosp ; 34(3): 616-621, 2020 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-32338020

RESUMO

INTRODUCTION: Introduction: glutamine (GLN), the most abundant non-essential amino acid in the plasma, tends to be rapidly depleted in cells in situations of metabolic stress. Some studies have demonstrated the benefits of GLN supplementation on mortality, infection, and length of hospital stay. The objective of this review was to analyze whether parenteral supplementation with GLN has any relevant effect in critically ill surgical patients. Methods: based on a systematic database search, randomized clinical trials (RCTs) published since 1985 were included if they had evaluated the effect of parenteral GLN supplementation in critical surgical patients. The statistical analysis was performed using the RevMan 5.3 software. Results: seven RCTs were eligible for the meta-analysis. Parenteral glutamine supplementation was associated with a non-significant 24 % reduction in mortality (RR = 0.76; 95 % CI: 0.50-1.15). Infections were significantly reduced (RR = 0.60; 95 % CI: 0.45-0.80), and length of hospital stay was 4.09 days shorter (95 % CI: -6.71 to -1.46). Conclusion: parenteral GLN usage in critical surgical patients seems to decrease infection and length of hospital stay, but we could not demonstrate a significant reduction in mortality.


INTRODUCCIÓN: Introducción: la glutamina (GLN), el aminoácido no esencial más abundante en el plasma, tiende a agotarse rápidamente en las células en situaciones de estrés metabólico. Algunos estudios han demostrado beneficios de la suplementación con GLN en términos de reducción de la mortalidad, las infecciones y la duración de la hospitalización. El objetivo de esta revisión es analizar si la suplementación parenteral de GLN tiene algún efecto relevante para los pacientes quirúrgicos en estado crítico. Métodos: basado en una búsqueda sistemática de bases de datos, se incluyeron ensayos clínicos aleatorizados (ECA) publicados desde 1985 si estos habían evaluado el efecto de la suplementación parenteral de GLN en pacientes quirúrgicos críticos. El análisis estadístico se realizó utilizando el software RevMan 5.3. Resultados: siete ECA fueron elegibles para el metaanálisis. La suplementación parenteral de glutamina se asoció a una reducción no significativa del 24 % en la mortalidad (RR = 0,76; IC 95 %: 0,50-1,15). Las infecciones se redujeron significativamente (RR = 0,60; IC 95 %: 0,45-0,80) y la duración de la estancia de hospitalización fue 4,09 días menor (IC 95 %: -6,71 a -1,46). Conclusión: El uso de GLN parenteral en pacientes quirúrgicos críticos parece disminuir las infecciones y la duración de la estancia hospitalaria, pero no pudimos demostrar una reducción significativa de la mortalidad.


Assuntos
Estado Terminal/terapia , Cirurgia Geral , Glutamina/administração & dosagem , Glutamina/uso terapêutico , Nutrição Parenteral , Mortalidade Hospitalar , Humanos , Tempo de Internação , Complicações Pós-Operatórias/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto
13.
Infect Dis Obstet Gynecol ; 2012: 378640, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23133306

RESUMO

Bacterial vaginosis, trichomoniasis, and genital candidiasis are considered the main etiologies of vulvovaginitis. Few studies estimate the prevalence of vulvovaginitis among adolescents, especially in Brazil. This study aimed to determine the prevalence and main risk factors associated with bacterial vaginosis and genital infection by C. albicans and Trichomonas vaginalis among a group of adolescents from Salvador, Bahia, Brazil. One hundred sexually active adolescents followed at an adolescent gynecology clinic were included. Endocervical and vaginal samples were obtained during gynecological examination. Nugent criteria were applied for the diagnosis of bacterial vaginosis. For Candida albicans and Trichomonas vaginalis detection, culture in Sabouraud agar plates and Papanicolaou cytology were used, respectively. The mean age of participants was 16.6 ± 1.6 years. The prevalence of bacterial vaginosis was 20% (95% CI 12-28) and of genital infection by Candida was 22% (95% CI 14-30). Vaginal cytology detected Trichomonas vaginalis in one patient. Alcohol, tobacco, and illegal drug use (P = 0.02) and multiple lifetime partners were statistically related to bacterial vaginosis (P = 0.01). The prevalence of bacterial vaginosis and genital candidiasis was similar to other studies carried out among adolescents worldwide.


Assuntos
Candidíase Vulvovaginal/epidemiologia , Comportamento Sexual/estatística & dados numéricos , Vaginose Bacteriana/epidemiologia , Adolescente , Brasil/epidemiologia , Feminino , Humanos , Prevalência , Fatores de Risco , Parceiros Sexuais , Transtornos Relacionados ao Uso de Substâncias/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA